Header

UZH-Logo

Maintenance Infos

Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF-Mutant Melanoma


Statistics

Citations

Dimensions.ai Metrics
6 citations in Web of Science®
6 citations in Scopus®
5 citations in Microsoft Academic
Google Scholar™

Altmetrics

Downloads

5 downloads since deposited on 30 Aug 2017
5 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Dermatology Clinic
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:13 June 2017
Deposited On:30 Aug 2017 13:09
Last Modified:13 Jun 2018 00:00
Publisher:American Association for Cancer Research
ISSN:1078-0432
OA Status:Green
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1158/1078-0432.CCR-16-2923
PubMed ID:28611198

Download

Download PDF  'Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF-Mutant Melanoma'.
Preview
Content: Accepted Version
Filetype: PDF
Size: 613kB
View at publisher